Speaking Roses International Inc.

Speaking Roses International Inc. markets, distributes, and retail floral products, primarily roses in the United States. It sells embossed flowers and bouquets to individuals, businesses, florists, chain stores, funeral homes, and wedding and corporate event planners. The company also owns a proprietary technology used to emboss flowers and floral products, as well as licenses its technology to wholesale flower concerns and other parties. This technology enables users to request personalized floral arrangements using standardized or unique messages, logos, trademarks, and pictures. The company was founded in 2003 and is based in Salt Lake City, Utah.

Speaking Roses International Inc. trades as SRII on OTC. The company is classified in Technology / Semiconductors and reports in USD.

The current profile places the business in Semiconductors. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Speaking Roses International Inc. can be compared against peers such as Ablaze Technologies Inc, BrightStar Information Technology Group, Inc., Deep Field Technologies, Inc., Ionix Technology, Inc., ITOCHU Techno-Solutions Corporation, ITOCHU Techno-Solutions Corporation.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $350, beta of 24.15, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SRII currently shows total debt of N/A and beta of 24.15. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website is not available.

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.